The Effect of Atorvastatin on Renal Function in Healthy Subjects During Normal and High Sodium Intake
NCT00678184 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2008-05-15
Summary
We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium handling, renal hemodynamics, tubular function and vasoactive hormones in healthy humans during normal and high sodium intake.
Conditions
- Healthy Subjects
Interventions
- DRUG
-
80 mg atorvastatin on two following days each
Sponsors & Collaborators
-
Regional Hospital Holstebro
lead OTHER
Principal Investigators
-
Erling B. Pedersen, Professor · Dept. of medical reaserch, Holstebro Hospital, Denmark
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2007-10-31
- Completion
- 2007-10-31
Countries
- Denmark
Study Locations
More Related Trials
-
Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT05870007 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney Disease
NCT03596957 ·Status: UNKNOWN ·Phase: PHASE4
-
Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.
NCT00407784 ·Status: UNKNOWN
-
Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
NCT00528385 ·Status: COMPLETED ·Phase: NA
-
Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker
NCT00310778 ·Status: COMPLETED ·Phase: PHASE1
-
Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease
NCT00865501 ·Status: COMPLETED ·Phase: PHASE3
-
CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function
NCT01678794 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
NCT00920764 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Acute L-NMMA Treatment on Renal Hemodynamics and Vasoactive Hormones in Patients With Congestive Heart Failure
NCT00344734 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart Failure
NCT00924014 ·Status: UNKNOWN ·Phase: NA
-
Hypertension in Hemodialysis Patients (Aim 3)
NCT00582114 ·Status: TERMINATED ·Phase: PHASE3
-
The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables
NCT01195805 ·Status: COMPLETED ·Phase: NA
-
Tolvaptan for Advanced or Refractory Heart Failure
NCT02959411 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of the Aquaretic Tolvaptan on Nitric Oxide System
NCT02527863 ·Status: COMPLETED ·Phase: PHASE2
-
Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure
NCT06233695 ·Status: COMPLETED
-
The Effect of Amiloride and Spironolactone in Patients With Hypertension
NCT01388088 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor
NCT01356849 ·Status: COMPLETED ·Phase: PHASE2
-
TRANSFORM-HF Ancillary Mechanistic Study
NCT04702958 ·Status: COMPLETED
-
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
NCT07020104 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Enalapril in Healthy Volunteers
NCT01115946 ·Status: COMPLETED ·Phase: PHASE1
-
Sex Differences in the Dilatory Response of Compound 21
NCT05576155 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Studies on Aldosterone and Vascular Function
NCT00700479 ·Status: COMPLETED ·Phase: PHASE1
-
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
NCT04040959 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney Disease
NCT01623661 ·Status: COMPLETED ·Phase: NA
-
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure
NCT06995144 ·Status: COMPLETED ·Phase: PHASE4